| Year |
Citation |
Score |
| 2023 |
Al Jamal I, Parquet M, Guiyedi K, Aoufouchi S, Le Guillou M, Rizzo D, Pollet J, Dupont M, Boulin M, Faumont N, Boutouil H, Jardin F, Ruminy P, El Hamel C, Lerat J, ... ... Gachard N, et al. IgH 3'RR recombination uncovers a non-germinal center imprint and c-MYC-dependent IgH rearrangement in unmutated chronic lymphocytic leukemia. Haematologica. PMID 37496419 DOI: 10.3324/haematol.2023.282897 |
0.641 |
|
| 2023 |
Perani A, Bourthoumieu S, Rizzo D, Chauzeix J, Dauriat B, Turlure P, Girault S, Veyrune L, Roubinet M, Feuillard J, Yardin C, Gachard N. Hereditary predisposition to malignant myeloid hemopathies: Caution in use of saliva and guideline based on our experience. Frontiers in Oncology. 13: 1120829. PMID 36923434 DOI: 10.3389/fonc.2023.1120829 |
0.494 |
|
| 2021 |
Aitamer M, Akil H, Vignoles C, Branchaud M, Abraham J, Gachard N, Feuillard J, Jauberteau MO, Shirvani H, Troutaud D, Bentayeb H. CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles. British Journal of Cancer. PMID 34743199 DOI: 10.1038/s41416-021-01611-7 |
0.622 |
|
| 2021 |
Ouk C, Roland L, Gachard N, Poulain S, Oblet C, Rizzo D, Saintamand A, Lemasson Q, Carrion C, Thomas M, Balabanian K, Espéli M, Parrens M, Soubeyran I, Boulin M, et al. Continuous MYD88 Activation Is Associated With Expansion and Then Transformation of IgM Differentiating Plasma Cells. Frontiers in Immunology. 12: 641692. PMID 34017329 DOI: 10.3389/fimmu.2021.641692 |
0.628 |
|
| 2021 |
Gayet M, Leymarie V, Derouault P, Guérin E, Vaidié J, Pascal V, Boulin M, Dmytruk N, Chauzeix J, Trimoreau F, Gachard N, Feuillard J, Rizzo D. Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia. Cytometry. Part B, Clinical Cytometry. PMID 33634586 DOI: 10.1002/cyto.b.21995 |
0.599 |
|
| 2020 |
Chauzeix J, Pastoret C, Donaty L, Gachard N, Fest T, Feuillard J, Rizzo D. A reduced panel of eight genes (ATM, SF3B1, NOTCH1, BIRC3, XPO1, MYD88, TNFAIP3, and TP53) as an estimator of the tumor mutational burden in chronic lymphocytic leukemia. International Journal of Laboratory Hematology. PMID 33325634 DOI: 10.1111/ijlh.13435 |
0.512 |
|
| 2020 |
Talbot H, Saada S, Barthout E, Gallet PF, Gachard N, Abraham J, Jaccard A, Troutaud D, Lalloué F, Naves T, Fauchais AL, Jauberteau MO. BDNF belongs to the nurse-like cell secretome and supports survival of B chronic lymphocytic leukemia cells. Scientific Reports. 10: 12572. PMID 32724091 DOI: 10.1038/S41598-020-69307-1 |
0.435 |
|
| 2019 |
Vincent-Fabert C, Soubeyran I, Velasco V, Parrens M, Jeannet R, Lereclus E, Gachard N, Feuillard J, Faumont N. Inflamed phenotype of splenic marginal zone B-cell lymphomas with expression of PD-L1 by intratumoral monocytes/macrophages and dendritic cells. Cellular & Molecular Immunology. PMID 30967638 DOI: 10.1038/S41423-019-0228-Y |
0.565 |
|
| 2019 |
Julien V, Rea D, Thepot S, Bruno LP, Gachard N, Struski S, Roy L, Bally C, Caers J, Nicolini FE, Cassinat B, Lippert E, Legros L, Itzykson R. Current Treatments Do Not Improve the Prognosis of Patients with Atypical CML and Unclassified MDS/MPN. a Joint Report from Fi-LMC, FIM, Gfch and GFM Blood. 134: 2954-2954. DOI: 10.1182/Blood-2019-127254 |
0.338 |
|
| 2019 |
Chauzeix J, Pastoret C, Donaty L, Gachard N, Fest T, Feuillard J, Rizzo D. TUMOR MUTATIONAL BURDEN ASSESSED BY TARGETED HIGH THROUGHPUT SEQUENCING PREDICTS TREATMENT FREE SURVIVAL IN CLL: RESULTS FROM A BICENTER STUDY Hemasphere. 3: 515-516. DOI: 10.1097/01.HS9.0000562836.24474.FE |
0.484 |
|
| 2018 |
Carrion C, Guérin E, Gachard N, le Guyader A, Giraut S, Feuillard J. Adult Bone Marrow Three-Dimensional Phenotypic Landscape of B-Cell Differentiation. Cytometry. Part B, Clinical Cytometry. PMID 30450798 DOI: 10.1002/Cyto.B.21747 |
0.56 |
|
| 2018 |
Duchesne M, Roussellet O, Maisonobe T, Gachard N, Rizzo D, Armand M, Viala K, Richard L, Delage-Corre M, Jaccard A, Corcia P, Vallat JM, Magy L. Pathology of Nerve Biopsy and Diagnostic Yield of PCR-Based Clonality Testing in Neurolymphomatosis. Journal of Neuropathology and Experimental Neurology. PMID 30011033 DOI: 10.1093/Jnen/Nly055 |
0.307 |
|
| 2018 |
Chauzeix J, Laforêt MP, Deveza M, Crowther L, Marcellaud E, Derouault P, Lia AS, Boyer F, Bargues N, Olombel G, Jaccard A, Feuillard J, Gachard N, Rizzo D. Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients. Cancer Medicine. PMID 29745034 DOI: 10.1002/Cam4.1510 |
0.585 |
|
| 2017 |
Abbaci A, Talbot H, Saada S, Gachard N, Abraham J, Jaccard A, Bordessoule D, Fauchais AL, Naves T, Jauberteau MO. Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis. Oncogene. PMID 29059151 DOI: 10.1038/Onc.2017.365 |
0.46 |
|
| 2017 |
Pham-Ledard A, Prochazkova-Carlotti M, Deveza M, Laforet MP, Beylot-Barry M, Vergier B, Parrens M, Feuillard J, Merlio JP, Gachard N. Molecular analysis of immunoglobulin variable genes supports a germinal center experienced normal counterpart in primary cutaneous diffuse large B-cell lymphoma, leg-type. Journal of Dermatological Science. PMID 28838616 DOI: 10.1016/J.Jdermsci.2017.07.008 |
0.64 |
|
| 2017 |
Lafage-Pochitaloff M, Baranger L, Hunault M, Cuccuini W, Lefebvre C, Bidet A, Tigaud I, Eclache V, Delabesse E, Bilhou-Nabéra C, Terré C, Chapiro E, Gachard N, Mozziconacci MJ, Ameye G, et al. Value of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia. Blood. PMID 28790105 DOI: 10.1182/Blood-2017-05-783852 |
0.372 |
|
| 2017 |
David A, Arnaud N, Fradet M, Lascaux H, Ouk-Martin C, Gachard N, Zimber-Strobl U, Feuillard J, Faumont N. C-Myc dysregulation is a co-transforming event for NF-κB activated B-cells. Haematologica. PMID 28232371 DOI: 10.3324/Haematol.2016.156281 |
0.791 |
|
| 2016 |
Troadec E, Dobbelstein S, Bertrand P, Faumont N, Trimoreau F, Touati M, Chauzeix J, Petit B, Bordessoule D, Feuillard J, Bastard C, Gachard N. A novel t(3;13)(q13;q12) translocation fusing FLT3 with GOLGB1: Toward myeloid/lymphoid neoplasms with eosinophilia and rearrangement of FLT3? Leukemia. PMID 27795560 DOI: 10.1038/Leu.2016.304 |
0.733 |
|
| 2016 |
Bally C, Lehmann-Che J, Cassinat B, Ades L, Letouze E, Hirsch P, Mozziconacci M, Raynaud S, Delabesse E, Uzunov M, Hunault M, Lippert E, Lapillonne H, Ferrand C, Gervais C, ... Gachard N, et al. Whole Exome Analysis of Relapsing Patients with Acute Promyelocytic Leukemia Blood. 128: 2892-2892. DOI: 10.1182/Blood.V128.22.2892.2892 |
0.357 |
|
| 2015 |
Rizzo D, Chauzeix J, Trimoreau F, Woillard JB, Genevieve F, Bouvier A, Labrousse J, Poli C, Guerin E, Dmytruk N, Remenieras L, Feuillard J, Gachard N. IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events. Leukemia. 29: 337-45. PMID 24943833 DOI: 10.1038/Leu.2014.198 |
0.58 |
|
| 2014 |
Cosson A, Chapiro E, Belhouachi N, Cung HA, Keren B, Damm F, Algrin C, Lefebvre C, Fert-Ferrer S, Luquet I, Gachard N, Mugneret F, Terre C, Collonge-Rame MA, Michaux L, et al. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma Genes Chromosomes and Cancer. 53: 657-666. PMID 24729385 DOI: 10.1002/Gcc.22176 |
0.398 |
|
| 2014 |
Chanut A, Duguet F, Marfak A, David A, Petit B, Parrens M, Durand-Panteix S, Boulin-Deveza M, Gachard N, Youlyouz-Marfak I, Bordessoule D, Feuillard J, Faumont N. RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cells. Leukemia. 28: 871-9. PMID 24056880 DOI: 10.1038/Leu.2013.274 |
0.674 |
|
| 2014 |
Lafage-Pochitaloff M, Baranger L, Hunault M, Cuccuini W, Bidet A, Dastugue N, Tigaud I, Henry C, Gervais C, Penther D, Lefebvre C, Nadal N, Mugneret F, Eclache V, Radford I, ... Gachard N, et al. Value of Cytogenetic Abnormalities in Adult Patients with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) Treated in the Pediatric-Inspired Trials from the Group for Research on Adult ALL (GRAALL) Blood. 124: 492-492. DOI: 10.1182/Blood.V124.21.492.492 |
0.334 |
|
| 2014 |
Pham-Ledard A, Prochazkova-Carlotti M, Deveza M, Beylot-Barry M, Vergier B, Parrens M, Merlio J, Feuillard J, Gachard N. La cellule d’origine du lymphome cutané B diffus à grandes cellules de type jambe : un lymphocyte B mature, post centre germinatif Annales De Dermatologie Et De VéNéRéOlogie. 141: S391. DOI: 10.1016/J.Annder.2014.09.369 |
0.532 |
|
| 2013 |
Sarkozy C, Gardin C, Gachard N, Merabet F, Turlure P, Malfuson JV, Pautas C, Micol JB, Thomas X, Quesnel B, Celli-Lebras K, Preudhomme C, Terré C, Fenaux P, Chevret S, et al. Outcome of older patients with acute myeloid leukemia in first relapse. American Journal of Hematology. 88: 758-64. PMID 23749683 DOI: 10.1002/Ajh.23498 |
0.309 |
|
| 2013 |
Rizzo D, Lotay A, Gachard N, Marfak I, Faucher JL, Trimoreau F, Guérin E, Bordessoule D, Jaccard A, Feuillard J. Very low levels of surface CD45 reflect CLL cell fragility, are inversely correlated with trisomy 12 and are associated with increased treatment-free survival. American Journal of Hematology. 88: 747-53. PMID 23733486 DOI: 10.1002/Ajh.23494 |
0.632 |
|
| 2013 |
Boudry-Labis E, Roche-Lestienne C, Nibourel O, Boissel N, Terre C, Perot C, Eclache V, Gachard N, Tigaud I, Plessis G, Cuccuini W, Geffroy S, Villenet C, Figeac M, Leprêtre F, et al. Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia. American Journal of Hematology. 88: 306-11. PMID 23460398 DOI: 10.1002/Ajh.23403 |
0.353 |
|
| 2013 |
Laforêt MP, Turlure P, Lippert E, Cornillet-Lefebvre P, Pigneux A, Pradeau R, Feuillard J, Gachard N. Design and feasibility of a novel, rapid, and simple fluorescence 26-plex RT-PCR assay for simultaneous detection of 24 fusion transcripts in adult acute myeloid leukemia Journal of Molecular Diagnostics. 15: 186-195. PMID 23318495 DOI: 10.1016/J.Jmoldx.2012.11.004 |
0.523 |
|
| 2013 |
Rizzo D, Bouvier G, Youlyouz-Marfak I, Guerin E, Trimoreau F, Bordessoule D, Jaccard A, Gachard N, Feuillard J. T/B ratio does not reflect levels of ZAP70 expression in clonal CLL B-cells due to ZAP70 overexpression in patient T-cells. Cytometry. Part B, Clinical Cytometry. 84: 125-32. PMID 23225571 DOI: 10.1002/Cyto.B.21055 |
0.64 |
|
| 2013 |
Nguyen-Khac F, Lambert J, Chapiro E, Grelier A, Mould S, Barin C, Daudignon A, Gachard N, Struski S, Henry C, Penther D, Mossafa H, Andrieux J, Eclache V, Bilhou-Nabera C, et al. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia Haematologica. 98: 649-654. PMID 23065509 DOI: 10.3324/Haematol.2012.070458 |
0.36 |
|
| 2013 |
Nguyen-Khac F, Cosson A, Chapiro E, Belhouachi N, Cung h, Keren B, Damm F, Algrin C, Lefebvre C, fert-Ferrer S, Luquet I, Gachard N, Mugneret F, Terré C, Collonge-Rame M, et al. NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Blood. 122: 2561-2561. DOI: 10.1182/Blood.V122.21.2561.2561 |
0.383 |
|
| 2012 |
Gachard N, Parrens M, Soubeyran I, Petit B, Marfak A, Rizzo D, Devesa M, Delage-Corre M, Coste V, Laforêt MP, de Mascarel A, Merlio JP, Bouabdhalla K, Milpied N, Soubeyran P, et al. IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. Leukemia. 27: 183-9. PMID 22944768 DOI: 10.1038/Leu.2012.257 |
0.587 |
|
| 2012 |
Borel C, Dastugue N, Cances-Lauwers V, Mozziconacci MJ, Prebet T, Vey N, Pigneux A, Lippert E, Visanica S, Legrand F, Rault JP, Taviaux S, Bastard C, Mugneret F, Collonges Rames MA, ... Gachard N, et al. PICALM-MLLT10 acute myeloid leukemia: a French cohort of 18 patients. Leukemia Research. 36: 1365-9. PMID 22871473 DOI: 10.1016/J.Leukres.2012.07.008 |
0.416 |
|
| 2012 |
Put N, Van Roosbroeck K, Konings P, Meeus P, Brusselmans C, Rack K, Gervais C, Nguyen-Khac F, Chapiro E, Radford-Weiss I, Struski S, Dastugue N, Gachard N, Lefebvre C, Barin C, et al. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. Annals of Hematology. 91: 863-73. PMID 22205151 DOI: 10.1007/S00277-011-1393-Y |
0.394 |
|
| 2011 |
Nguyen-Khac F, Chapiro E, Lesty C, Grelier A, Luquet I, Radford-Weiss I, Lefebvre C, Fert-Ferrer S, Callet-Bauchu E, Lippert E, Raggueneau V, Michaux L, Barin C, Collonge-Rame MA, Mugneret F, ... ... Gachard N, et al. Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia. American Journal of Blood Research. 1: 13-21. PMID 22432063 DOI: 10.1182/Blood.V116.21.582.582 |
0.338 |
|
| 2011 |
Jaccard A, Gachard N, Marin B, Rogez S, Audrain M, Suarez F, Tilly H, Morschhauser F, Thieblemont C, Ysebaert L, Devidas A, Petit B, de Leval L, Gaulard P, Feuillard J, et al. Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study. Blood. 117: 1834-9. PMID 21123825 DOI: 10.1182/Blood-2010-09-307454 |
0.601 |
|
| 2011 |
Sarkozy C, Gardin C, Gachard N, Merabet F, Turlure P, Malfuson J, Pautas C, Micol J, Thomas X, Quesnel B, Celli-Lebras K, Preudhomme C, Terré C, Chevret S, Michallet M, et al. Older Patients with Acute Myeloid Leukemia (AML) in First Relapse: Impact of Genetics and of Salvage Therapy. A Study of the Acute Leukemia French Association (ALFA) Blood. 118: 253-253. DOI: 10.1182/Blood.V118.21.253.253 |
0.334 |
|
| 2011 |
Trimoreau F, Gachard N, Leymarie V, Frébet E, Perroud P, Feuillard J. Étapes préanalytiques pour la numération et cytologie sanguine Emc - Biologie MéDicale. 6: 1-10. DOI: 10.1016/S2211-9698(11)71443-1 |
0.445 |
|
| 2011 |
Trimoreau F, Guérin E, Gachard N, Leymarie V, Faucher J, Feuillard J, Béné M. Étapes préanalytiques pour la cytométrie en flux appliquée aux hémopathies Emc - Biologie MéDicale. 6: 1-6. DOI: 10.1016/S2211-9698(11)71442-X |
0.436 |
|
| 2011 |
Trimoreau F, Gachard N, Vrain A, Leymarie V, Perroud P, Feuillard J. Étapes préanalytiques pour la cytologie médullaire, ganglionnaire et des liquides biologiques Emc - Biologie MéDicale. 6: 1-8. DOI: 10.1016/S2211-9698(11)71441-8 |
0.441 |
|
| 2011 |
Gourin M, Gachard N, Trimoreau F, Abraham J, Moreau S, Mallissein E, Touati M, Feuillard J, Bordessoule D. 148 Myelodysplastic syndrome in very elderly patients: practice in the real life. Preliminary results on a monocentric cohort Leukemia Research. 35: S58. DOI: 10.1016/S0145-2126(11)70150-3 |
0.516 |
|
| 2010 |
Nguyen-Khac F, Lesty C, Eclache V, Couronné L, Kosmider O, Andrieux J, Collonge-Rame MA, Penther D, Lafage M, Bilhou-Nabera C, Chapiro E, Mozziconacci MJ, Mugneret F, Gachard N, Nadal N, et al. Chromosomal abnormalities in transformed Ph-negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations Genes Chromosomes and Cancer. 49: 919-927. PMID 20629097 DOI: 10.1002/Gcc.20802 |
0.343 |
|
| 2010 |
Lippert E, Etienne G, Mozziconacci MJ, Laibe S, Gervais C, Girault S, Gachard N, Tigaud I, Dastugue N, Huguet F, Fort MP, Legros L, Eclache V, Mahon FX. Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy. Haematologica. 95: 1604-7. PMID 20435623 DOI: 10.3324/Haematol.2009.019109 |
0.324 |
|
| 2010 |
Touati M, Gourin M, Abraham J, Weinbreck N, Gachard N, Olivrie-Gamaury A, Feuillard J, Jaccard A, Bordessoule D. Epidemiological review of lymphoma diagnosis in a French rural area between 2003 and 2008. Journal of Clinical Oncology. 28: e18551-e18551. DOI: 10.1200/Jco.2010.28.15_Suppl.E18551 |
0.579 |
|
| 2010 |
Gourin M, Turlure P, Gachard N, Girault S, Touati M, Abraham J, Philippon C, Feuillard J, Bordessoule D. Increased of overall survival (OS) and malignancies (K) during tyrosine kinase inhibitors (TKI) in a real life cohort of patients (pts) with a chronic myeloid leukemia (CML). Journal of Clinical Oncology. 28: 6602-6602. DOI: 10.1200/Jco.2010.28.15_Suppl.6602 |
0.552 |
|
| 2010 |
Nguyen-Khac F, Lejeune J, Chapiro E, Grelier A, Mould S, Barin C, Daudignon A, Gachard N, Struski S, Henry C, Penther D, Mossafa H, Andrieux J, Veronese L, Eclache V, et al. Cytogenetic Abnormalities In a Cohort of 171 Patients with Waldenström Macroglobulinemia Before Treatment: Clinical and Biological Correlations Blood. 116: 801-801. DOI: 10.1182/Blood.V116.21.801.801 |
0.381 |
|
| 2010 |
Labis E, Roche-Lestienne C, Nibourel O, Boissel N, Roumier C, Terre C, Perot C, Eclache V, Gachard N, Tigaud I, Plessis G, Cuccuini W, Geffroy S, Helevaut N, Quief S, et al. Deletion of the Tumor Suppressor Gene NF1 Is Found In 3.5% of 485 De Novo Adult Myeloid Leukemia and Is Correlated with Unfavourable Cytogenetic: On Behalf of the ALFA Group Blood. 116: 4171-4171. DOI: 10.1182/Blood.V116.21.4171.4171 |
0.369 |
|
| 2009 |
Petit B, Parrens M, Soubeyran I, Costes-Martineau V, Gachard N, Boulin M, Laurent C, Marfak A, Labrousse F, Bordessoule D, Feuillard J. Among 157 marginal zone lymphomas, DBA.44(CD76) expression is restricted to tumour cells infiltrating the red pulp of the spleen with a diffuse architectural pattern. Histopathology. 54: 626-31. PMID 19413643 DOI: 10.1111/J.1365-2559.2009.03262.X |
0.597 |
|
| 2009 |
Renneville A, Boissel N, Gachard N, Naguib D, Bastard C, de Botton S, Nibourel O, Pautas C, Reman O, Thomas X, Gardin C, Terré C, Castaigne S, Preudhomme C, Dombret H. The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplication. Blood. 113: 5090-3. PMID 19289855 DOI: 10.1182/Blood-2008-12-194704 |
0.351 |
|
| 2009 |
Jaccard A, Petit B, Girault S, Suarez F, Gressin R, Zini JM, Coiteux V, Larroche C, Devidas A, Thiéblemont C, Gaulard P, Marin B, Gachard N, Bordessoule D, Hermine O. L-asparaginase-based treatment of 15 western patients with extranodal NK/T-cell lymphoma and leukemia and a review of the literature. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 20: 110-6. PMID 18701429 DOI: 10.1093/Annonc/Mdn542 |
0.386 |
|
| 2009 |
Turlure P, Gachard N, Gourin M, Girault S, Touati M, Remenieras L, Moreau S, Philippon C, Lefort S, Feuillard J, Bordessoule D. Improved Survival in Recent Years of Chronic Myeloid Leukemia (CML) Observed in the Real World in a Cohort of Patients Cared in a Haematological Regional Network HEMATOLIM. Blood. 114: 4283-4283. DOI: 10.1182/Blood.V114.22.4283.4283 |
0.554 |
|
| 2009 |
Nguyen-Khac F, Couronne L, Eclache V, Andrieux J, Lippert E, Kosmider O, Mugneret F, Collonge-Rame M, Penther D, Lafage M, Gachard N, Nadal N, Mozziconacci M, Dastugue N, Bilhou-Nabera C, et al. Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2 and the TET2 Statuses. Blood. 114: 2900-2900. DOI: 10.1182/Blood.V114.22.2900.2900 |
0.378 |
|
| 2009 |
Gourin M, Trimoreau F, Gachard N, Faucher J, Abraham J, Dmytruk N, Moreau S, Lamarche F, Girault S, Turlure P, Feuillard J, Bordessoule D. Is It Relevant to Determine Routinely Levels of Circulating NK and NK Like Cells in Myelodyplastic Syndroms?. Blood. 114: 2786-2786. DOI: 10.1182/Blood.V114.22.2786.2786 |
0.589 |
|
| 2008 |
Parrens M, Gachard N, Petit B, Marfak A, Troadec E, Bouabdhalla K, Milpied N, Merlio JP, de Mascarel A, Laurent C, Soubeyran I, Coste V, Labrousse F, Cogné M, Feuillard J. Splenic marginal zone lymphomas and lymphoplasmacytic lymphomas originate from B-cell compartments with two different antigen-exposure histories. Leukemia. 22: 1621-4. PMID 18305562 DOI: 10.1038/Leu.2008.24 |
0.77 |
|
| 2008 |
Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B, Leprêtre S, Olschwang S, Jardin F, Lafage-Pochitaloff M, Penther D, Sainty D, Reminieras L, Feuillard J, Béné MC, et al. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. Haematologica. 93: 215-23. PMID 18223290 DOI: 10.3324/Haematol.11622 |
0.632 |
|
| 2008 |
Jaccard A, Gachard N, Coppo P, Morschhauser F, Galicier L, Ysebaert L, Lenain P, Corront B, Suarez F, Feuillard J, Gaulard P, Bordessoule D, Hermine O. A Prospective Phase II Trial of An L-Asparaginase Containing Regimen in Patients with Refractory or Relapsing Extra Nodal NK/T-Cell Lymphoma Blood. 112: 579-579. DOI: 10.1182/Blood.V112.11.579.579 |
0.596 |
|
| 2008 |
Lippert E, Laibe S, Mozziconacci M, Gervais C, Girault S, Gachard N, Tigaud I, Dastugue N, Huguet F, Fort M, Eclache V, Mahon F. Loss of the Y Chromosome in Philadelphia-Positive Cells Predicts a Poor Response of CML Patients to Imatinib Mesylate Therapy. Blood. 112: 2117-2117. DOI: 10.1182/Blood.V112.11.2117.2117 |
0.346 |
|
| 2008 |
Nguyen-Khac F, Chapiro E, Mould S, Barin C, Daudignon A, Gachard N, Struski S, Henry C, Penther D, Mossafa H, Andrieux J, Perissel B, Eclache V, Bilhou-Nabera C, Luquet I, et al. Deletions of Chromosomes 6q and 13q, and Trisomy 4 Are the Most Common Cytogenetic Abnormalities in Waldenstrom Macroglobulinemia. Preliminary Results of a Multicentric Study. Blood. 112: 1771-1771. DOI: 10.1182/Blood.V112.11.1771.1771 |
0.356 |
|
| 2008 |
Renneville A, Castaigne S, Chevret S, Llopis L, Philippe N, Nibourel O, Hayette S, Cayuela J, Naguib D, Gachard N, Bories D, Bastard C, Merabet F, Pautas C, Terré C, et al. Incidence and Prognostic Impact of Gene Mutations in Older Patients with AML Treated in the ALFA-9801 Study. Blood. 112: 1525-1525. DOI: 10.1182/Blood.V112.11.1525.1525 |
0.321 |
|
| 2008 |
Borel C, Dastugue N, Prebet T, Vey N, Mozziconacci M, Bastard C, Lefebvre C, Mugneret F, Leroux D, Legrand F, Rame MAC, Visanica S, Rault JP, Gachard N, Pigneux A, et al. CALM-AF10 Positive Acute Myeloid Leukemias: A French Cohort of 18 Patients. Blood. 112: 1496-1496. DOI: 10.1182/Blood.V112.11.1496.1496 |
0.362 |
|
| 2007 |
Youlyouz-Marfak I, Gachard N, Le Clorennec C, Najjar I, Baran-Marszak F, Reminieras L, May E, Bornkamm GW, Fagard R, Feuillard J. Identification of a novel p53-dependent activation pathway of STAT1 by antitumour genotoxic agents. Cell Death and Differentiation. 15: 376-85. PMID 17992189 DOI: 10.1038/Sj.Cdd.4402270 |
0.585 |
|
| 2007 |
Terré C, Gardin C, Gachard N, Tigaud I, Désangles F, Bastard C, Maarek O, Lai J, Bernheim A, Perot C, Nguyen-Khac F, Eclache V, Plessis G, Turlure P, Thomas X, et al. Prognostic Impact of Cytogenetic Abnormalities in Elderly Patients with Acute Myeloid Leukemia (AML) Enrolled in the ALFA-9803 Trial. Blood. 110: 4233-4233. DOI: 10.1182/Blood.V110.11.4233.4233 |
0.328 |
|
| 2005 |
Petit B, Chaury MP, Le Clorennec C, Jaccard A, Gachard N, Moalic-Judge S, Labrousse F, Cogné M, Bordessoule D, Feuillard J. Indolent lymphoplasmacytic and marginal zone B-cell lymphomas: absence of both IRF4 and Ki67 expression identifies a better prognosis subgroup. Haematologica. 90: 200-6. PMID 15710572 |
0.777 |
|
| 2005 |
Youlyouz-Marfak I, Le Clorennec C, Najjar I, Baran-Marszak F, Gachard N, Remenieras L, Jaccard A, Bornkamm GW, Fagard R, Feuillard J. Antitumor Genotoxic Agents, Such as Fludarabine*, Doxorubincin or Cis-Platine, Induce Activation of STAT1 in a p53 Protein Dependent Manner. Blood. 106: 4384-4384. DOI: 10.1182/Blood.V106.11.4384.4384 |
0.607 |
|
| 2004 |
Gachard N, Turlure P, Trimoreau F, Moreau S, Donnard M, Chaury M, Pradeau R, Bordessoule D, Feuillard J. Quantification of MDM2 Gene Expression Level by RQ-PCR Is Predictive of the First Complete Remission in Adulte Acute Myeloid Leukaemia. Blood. 104: 1068-1068. DOI: 10.1182/Blood.V104.11.1068.1068 |
0.602 |
|
| 2003 |
Trimoreau F, Donnard M, Turlure P, Gachard N, Bordessoule D, Feuillard J. The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies. Haematologica. 88: ELT10. PMID 12651292 |
0.471 |
|
| 2002 |
Leroux D, Mugneret F, Callanan M, Radford-Weiss I, Dastugue N, Feuillard J, Le Mée F, Plessis G, Talmant P, Gachard N, Uettwiller F, Pages MP, Mozziconacci MJ, Eclache V, Sibille C, et al. CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique. Blood. 99: 4154-9. PMID 12010820 DOI: 10.1182/Blood.V99.11.4154 |
0.588 |
|
| 1998 |
Liozon E, Touati M, Allegraud A, Gachard N, Loustaud V, Vidal E, Bordessoule D. Thymoma-associated pancytopenia: effectiveness of cyclosporine A. Annals of Hematology. 77: 175-8. PMID 9829850 DOI: 10.1007/S002770050437 |
0.325 |
|
| Show low-probability matches. |